The DOI matches its Crossref record, with a small difference in title or year; 130 of the 130 references it cites were found in a registry or an index.
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis
Open accessAbstract
IMPORTANCE: Neurofilament light protein (NfL) is elevated in cerebrospinal fluid (CSF) of a number of neurological conditions compared with healthy controls (HC) and is a candidate biomarker for neuroaxonal damage. The influence of age and sex is largely unknown, and levels across neurological disorders have not been compared systematically to date. OBJECTIVES: To assess the associations of age, sex, and diagnosis with NfL in CSF (cNfL) and to evaluate its potential in discriminating clinically similar conditions. DATA SOURCES: PubMed was searched for studies published between January 1, 2006, and January 1, 2016, reporting cNfL levels (using the search terms neurofilament light and cerebrospinal fluid) in neurological or psychiatric conditions and/or in HC. STUDY SELECTION: Studies reporting NfL levels measured in lumbar CSF using a commercially available immunoassay, as well as age and sex. DATA EXTRACTION AND SYNTHESIS: Individual-level data were requested from study authors. Generalized linear mixed-effects models were used to estimate the fixed effects of age, sex, and diagnosis on log-transformed NfL levels, with cohort of origin modeled as a random intercept. MAIN OUTCOME AND MEASURE: The cNfL levels adjusted for age and sex across diagnoses. RESULTS: Data were collected for 10 059 individuals (mean [SD] age, 59.7 [18.8] years; 54.1% female). Thirty-five diagnoses were identified, including inflammatory diseases of the central nervous system (n = 2795), dementias and predementia stages (n = 4284), parkinsonian disorders (n = 984), and HC (n = 1332). The cNfL was elevated compared with HC in a majority of neurological conditions studied. Highest levels were observed in cognitively impaired HIV-positive individuals (iHIV), amyotrophic lateral sclerosis, frontotemporal dementia (FTD), and Huntington disease. In 33.3% of diagnoses, including HC, multiple sclerosis, Alzheimer disease (AD), and Parkinson disease (PD), cNfL was higher in men than women. The cNfL increased with age in HC and a majority of neurological conditions, although the association was strongest in HC. The cNfL overlapped in most clinically similar diagnoses except for FTD and iHIV, which segregated from other dementias, and PD, which segregated from atypical parkinsonian syndromes. CONCLUSIONS AND RELEVANCE: These data support the use of cNfL as a biomarker of neuroaxonal damage and indicate that age-specific and sex-specific (and in some cases disease-specific) reference values may be needed. The cNfL has potential to assist the differentiation of FTD from AD and PD from atypical parkinsonian syndromes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802
Self-citationMcDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H., Kappos, L., Lublin, F. D., Metz, L. M., McFarland, H. F., O'Connor, P. W., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20703 · Cited by 5,017
Self-citationDiagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476
Research works printed but not linked: 2
- Vandenbroucke, 2007, 18, 805
- Tortorella, Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis [published correction appears in Mult Scler. 2019;25(2):302]., Mult Scler J
Cited by
Sorted by citations
Items 101–200 of 771
Plasma neurofilament light chain: an early biomarker for hereditary ATTR amyloid polyneuropathy
Maia, L. F., Maceski, A. M., Conceição, I. M., Obici, L. P., Magalhães, R., Cortese, A., Leppert, D., Merlini, G., Kühle, J., & Saraiva, M. J. (2020) · Amyloid · doi:10.1080/13506129.2019.1708716 · Cited by 64
Advances in Proteomic and Metabolomic Profiling of Neurodegenerative Diseases
Schuh, A. F. S., Bieger, A., Borelli, W. V., Portley, M. K., Awad, P. S., & Bandrés‐Ciga, S. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.792227 · Cited by 68
The road to precision medicine: Eliminating the “One Size Fits All” approach in Alzheimer’s disease
Behl, T., Kaur, I., Sehgal, A., Singh, S., Albarrati, A., Albratty, M., Najmi, A., Meraya, A. M., & BUNGAU, S. G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113337 · Cited by 67
VandeVrede, L. A., Cho, H., Sanderson‐Cimino, M. E., Wekselman, F., Cobigo, Y., Gorno‐Tempini, M. L., Heuer, H. W., Kramer, J. H., Lago, A. L., Leichter, D., et al. (2025) · JAMA Neurology · doi:10.1001/jamaneurol.2024.5017 · Cited by 68
Self-citationAlzheimer’s disease biomarkers and their current use in clinical research and practice
Hunter, T., Santos, L. E., Tovar-Moll, F. F., & Felice, F. G. D. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02709-z · Cited by 78
Biomarker-guided decision making in clinical drug development for neurodegenerative disorders
Cummings, J. L., Teunissen, C. E., Fiske, B. K., Ber, I. L., Wildsmith, K. R., Schöll, M., Dunn, B., & Scheltens, P. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01165-w · Cited by 70
Self-citationMielke, M. M., Syrjanen, J. A., Blennow, K., Zetterberg, H., Skoog, I. G., Vemuri, P., Machulda, M. M., Graff‐Radford, J., Knopman, D. S., Jack, C. R., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.07.009 · Cited by 62
Self-citationHjartarson, H. T., Nathorst-Böös, K., & Sejersen, T. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s214174 · Cited by 69
Zetterberg, H. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12618 · Cited by 59
Self-citationChhatwal, J. P., Schultz, A. P., Dang, Y., Ostaszewski, B., Liu, L., Yang, H.-S., Johnson, K. A., Sperling, R. A., & Selkoe, D. J. (2020) · Nature Communications · doi:10.1038/s41467-020-19543-w · Cited by 60
van den Bosch, A., Fransen, N., Mason, M., Rozemuller, A. J., Teunissen, C., Smolders, J., & Huitinga, I. (2022) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001154 · Cited by 58
Self-citationFluid biomarkers in Alzheimer's disease
Simrén, J., Elmgren, A., Blennow, K., & Zetterberg, H. (2023) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2022.09.006 · Cited by 58
Self-citationTypes and Concentrations of Blood-Based Biomarkers in Adults With Peripheral Neuropathies
Fundaun, J., Kolski, M. C., Álvarez, M. M., Baskozos, G., & Schmid, A. B. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.48593 · Cited by 63
Remnestål, J., Öijerstedt, L., Ullgren, A., Olofsson, J., Bergström, S., Kultima, K., Ingelsson, M., Kilander, L., Uhlén, M., Månberg, A., et al. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00198-y · Cited by 56
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia
van der Ende, E. L., Bron, E. E., Poos, J. M., Jiskoot, L. C., Panman, J. L., Papma, J. M., Meeter, L. H. H., Dopper, E. G. P., Wilke, C., Synofzik, M., et al. (2021) · Brain · doi:10.1093/brain/awab382 · Cited by 61
Self-citationSchultz, S. A., Strain, J. F., Adedokun, A., Wang, Q., Preische, O., Kühle, J., Flores, S. E., Keefe, S., Dincer, A., Ances, B. M., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104960 · Cited by 58
Personalized extended interval dosing of natalizumab in MS
van Kempen, Z. L. E., Hoogervorst, E. L. J., Wattjes, M. P., Kalkers, N. F., Mostert, J. P., Lissenberg-Witte, B. I., de Vries, A., ten Brinke, A., van Oosten, B. W., Barkhof, F., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009995 · Cited by 58
Self-citationPlasma neurofilament light chain as a potential biomarker in Charcot‐Marie‐Tooth disease
Millere, E., Rots, D., Simrén, J., Ashton, N. J., Kupats, E., Mičule, I., Priedīte, V., Kurjāne, N., Blennow, K., Gailīte, L., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14689 · Cited by 56
Self-citationLin, T., Vitkova, V., Asseyer, S., Serra, I. M., Motamedi, S., Chien, C., Ditzhaus, M., Papadopoulou, A., Benkert, P., Kühle, J., et al. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001051 · Cited by 59
Saracino, D., Dorgham, K., Camuzat, A., Rinaldi, D., Rametti‐Lacroux, A., Houot, M., Clot, F., Martin-Hardy, P., Jornéa, L., Azuar, C., et al. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2021-326914 · Cited by 64
Pratt, J., VITO, G. D., Segurado, R., Pessanha, L., Dolan, J., Narici, M. V., & Boreham, C. A. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12979 · Cited by 55
Ning, L., & Wang, B. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274565 · Cited by 65
How should we be using biomarkers in trials of disease modification in Parkinson’s disease?
Vijiaratnam, N., & Foltynie, T. (2023) · Brain · doi:10.1093/brain/awad265 · Cited by 56
del Campo, M., Zetterberg, H., Gandy, S., Onyike, C. U., Oliveira, F., Udeh‐Momoh, C., Lleó, A., Teunissen, C. E., & Pijnenburg, Y. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12643 · Cited by 52
Self-citationBlood biomarkers for Alzheimer's disease and related disorders
Zetterberg, H., & Schott, J. M. (2022) · Acta Neurologica Scandinavica · doi:10.1111/ane.13628 · Cited by 55
Self-citationZhu, S., Wuolikainen, A., Wu, J., Öhman, A., Wingsle, G., Möritz, T., Andersen, P. M., Forsgren, L., & Trupp, M. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01411-y · Cited by 54
Self-citationPalermo, G., Mazzucchi, S., Vecchia, A. D., Siciliano, G., Bonuccelli, U., Azuar, C., Ceravolo, R., Lista, S., Hampel, H. J., & Baldacci, F. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02035-9 · Cited by 55
Bridel, C., Leurs, C. E., van Lierop, Z. Y. G. J., van Kempen, Z. L. E., Dekker, I., Twaalfhoven, H. A. M., Moraal, B., Barkhof, F., Uitdehaag, B. M. J., Killestein, J., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012752 · Cited by 52
Self-citationthe INSIGHT-preAD study group, Baldacci, F., (APMI), F. T. A. P. M. I., Lista, S., Manca, M. L., Chiesa, P. A., Cavedo, E., Lemercier, P., Zetterberg, H., Blennow, K., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00704-4 · Cited by 53
Self-citationMulti‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease
Bergström, S., Remnestål, J., Yousef, J., Olofsson, J., Markaki, I., Carvalho, S., Corvol, J., Kultima, K., Kilander, L., Löwenmark, M., et al. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51402 · Cited by 48
Self-citationNeurofilament light chain and glial fibrillary acidic protein levels in metachromatic leukodystrophy
Beerepoot, S., Heijst, H., Roos, B., Wamelink, M. M. C., Boelens, J. J., Lindemans, C. A., van Hasselt, P. M., Jacobs, E. H., van der Knaap, M. S., Teunissen, C. E., et al. (2021) · Brain · doi:10.1093/brain/awab304 · Cited by 51
Self-citationPlasma p‐tau231 and p‐tau217 inform on tau tangles aggregation in cognitively impaired individuals
Ferreira, P. C. L., Therriault, J., Tissot, C., Ferrari‐Souza, J. P., Benedet, A. L., Povala, G., Bellaver, B., Leffa, D. T., Brum, W. S., Lussier, F. Z., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13393 · Cited by 53
Self-citationBolsewig, K., van Unnik, A. A. J. M., Blujdea, E. R., González, M. C., Ashton, N. J., Aarsland, D., Zetterberg, H., Padovani, A., Bonanni, L., Mollenhauer, B., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209418 · Cited by 57
Self-citationRatio and index of Neurofilament light chain indicate its origin in Guillain‐Barré Syndrome
Körtvelyessy, P., Kühle, J., Düzel, E., Vielhaber, S., Schmidt, C., Heinius, A., Leypoldt, F., Schraven, B. L., Reinhold, D., Leppert, D., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51207 · Cited by 51
Hepatic and renal function impact concentrations of plasma biomarkers of neuropathology
Berry, K., Asken, B. M., Grab, J. D., Chan, B., Lago, A. L., Wong, R. J., Seetharaman, S., LaHue, S. C., Possin, K. L., Rojas, J. C., et al. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12321 · Cited by 51
Self-citationObrocki, P., Khatun, A., Ness, D., Senkevich, K. A., Hanrieder, J., Capraro, F., Mattsson, N., Andréasson, U., Portelius, E., Ashton, N. J., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00586-6 · Cited by 51
Self-citationAfrican Americans Have Differences in CSF Soluble TREM2 and Associated Genetic Variants
Schindler, S. E., Cruchaga, C., Joseph, A., McCue, L. M., Farias, F., Wilkins, C. H., Deming, Y. K., Henson, R. L., Mikesell, R. J., Piccio, L. M., et al. (2021) · Neurology Genetics · doi:10.1212/nxg.0000000000000571 · Cited by 50
Schindler, S. E., & Atri, A. (2023) · Nature Aging · doi:10.1038/s43587-023-00400-6 · Cited by 49
Paterson, R. W., Benjamin, L. A., Mehta, P. R., Brown, R. L., Athauda, D. S., Ashton, N. J., Leckey, C. A., Ziff, O. J., Heaney, J., Heslegrave, A., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab099 · Cited by 53
Self-citationPilotto, A., Imarisio, A., Carrarini, C., Russo, M., Masciocchi, S., Gipponi, S., Cottini, E., Aarsland, D., Zetterberg, H., Ashton, N. J., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210342 · Cited by 49
Self-citationBiomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis
Katzeff, J. S., Bright, F., Phan, K., Kril, J. J., Ittner, L. M., Kassiou, M., Hodges, J. R., Piguet, O., Kiernan, M. C., Halliday, G. M., et al. (2022) · Brain · doi:10.1093/brain/awac077 · Cited by 48
Biomarkers of Alzheimer’s disease: Past, present and future clinical use
Georgakas, J. E., Howe, M. D., Thompson, L. I., Riera, N. M., & Riddle, M. C. (2023) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2023.100063 · Cited by 52
Development of an age‐adjusted model for blood neurofilament light chain
Harp, C. T., Thanei, G., Jia, X., Kühle, J., Leppert, D., Schaedelin, S. A., Benkert, P., von Büdingen, H., Hendricks, R., & Herman, A. H. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51524 · Cited by 52
Salvadó, G., Larsson, V., Cody, K. A., Cullen, N. C., Jonaitis, E. M., Stomrud, E., Kollmorgen, G., Wild, N., Palmqvist, S., Janelidze, S., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12907 · Cited by 46
Self-citationWilke, C., Reich, S., Swieten, J. C. V., Borroni, B., Sánchez‐Valle, R., Moreno, F., Laforce, R. J., Graff, C., Galimberti, D., Rowe, J. B., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26265 · Cited by 49
Eratne, D., Loi, S. M., Li, Q., Stehmann, C., Malpas, C. B., Santillo, A. F., Janelidze, S., Cadwallader, C. J., Walia, N., Ney, B., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12549 · Cited by 46
Self-citationDomínguez-Fernández, C., Egiguren-Ortiz, J., Razquin, J., Gómez-Galán, M., Heras-García, L. D. L., Paredes-Rodriguez, E., Astigarraga, E., Miguélez, C., & Barreda‐Gómez, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043321 · Cited by 52
Uman-type neurofilament light antibodies are effective reagents for the imaging of neurodegeneration
Shaw, G., Madorsky, I., Li, Y., Wang, Y.-S., Jorgensen, M., Rana, S. D., & Fuller, D. D. (2023) · Brain Communications · doi:10.1093/braincomms/fcad067 · Cited by 49
Katayama, T., Sawada, J., Takahashi, K., & Yahara, O. (2020) · Brain Sciences · doi:10.3390/brainsci10070466 · Cited by 48
Associations of sNfL with clinico‐radiological measures in a large MS population
Sotirchos, E. S., Fitzgerald, K. C., Singh, C. M., Smith, M. D., Reyes-Mantilla, M. I., Hersh, C. M., Hyland, M. H., Canissario, R., Simmons, S. B., Arrambide, G., et al. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51704 · Cited by 46
Inflammation in multiple system atrophy
Leńska-Mieciek, M., Madetko-Alster, N., Alster, P., Królicki, L., Fiszer, U., & Koziorowski, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1214677 · Cited by 45
Early Intrathecal T Helper 17.1 Cell Activity in Huntington Disease
von Essen, M. R., Hellem, M. N. N., Vinther‐Jensen, T., Ammitzbøll, C., Hansen, R. H., Hjermind, L. E., Nielsen, T. T., Nielsen, J. E., & Sellebjerg, F. T. (2019) · Annals of Neurology · doi:10.1002/ana.25647 · Cited by 46
Self-citationTarga, A., Dakterzada, F., Benitez, I. D., Ortega, R. L., Pujol, M., Dalmases, M., Arias, A. M., Sánchez‐de‐la‐Torre, M., Zetterberg, H., Blennow, K., et al. (2020) · SLEEP · doi:10.1093/sleep/zsaa147 · Cited by 47
Self-citationVacchiano, V., Mastrangelo, A., Zenesini, C., Baiardi, S., Avoni, P., Polischi, B., Capellari, S., Salvi, F., Liguori, R., & Parchi, P. (2023) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2022-330709 · Cited by 49
Bayoumy, S., Verberk, I. M. W., Vermunt, L., Willemse, E. A. J., den Dulk, B., van der Ploeg, A. T., Pajkrt, D., Nitz, E., van den Hout, J. M. P., van der Post, J., et al. (2024) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-1311 · Cited by 44
Self-citationNeurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis
Fox, R. J., Raska, P., Barro, C., Karafa, M., König, V., Bermel, R. A., Chase, M. K., Coffey, C. S., Goodman, A. D., Klawiter, E. C., et al. (2021) · Multiple Sclerosis Journal · doi:10.1177/1352458520986956 · Cited by 44
Eratne, D., Kang, M. J., Malpas, C. B., Simpson, S., Lewis, C. C., Dang, C., Grewal, J. K., Coe, A., Dobson, H., Keem, M. H., et al. (2023) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674231187312 · Cited by 43
Self-citationSaller, T., Petzold, A., Zetterberg, H., Kühle, J., Chappell, D., von Dossow, V., Klawitter, F., Schürholz, T., Hagl, C. M., Reuter, D. A., et al. (2019) · Biomedical Papers · doi:10.5507/bp.2019.043 · Cited by 43
Self-citationSerum neurofilament light chain
Aktaş, O., Renner, A., Huss, A. M., Filser, M., Baetge, S. J., Stute, N., Gasis, M., Lepka, K., Goebels, N., Şenel, M., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000885 · Cited by 43
Clinical implication of serum biomarkers and patient age in inflammatory demyelinating diseases
Lee, E., Lim, Y., Kim, S., Choi, L., Kim, H., Kim, K., Kim, H. W., Lee, J. S., & Kim, K. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51070 · Cited by 44
Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy
Hayashi, T., Nukui, T., Piao, J., Sugimoto, T., Anada, R., Matsuda, N., Yamamoto, M., Konishi, H., Dougu, N., & Nakatsuji, Y. (2021) · Brain and Behavior · doi:10.1002/brb3.2084 · Cited by 42
Lukkarinen, H., Jeppsson, A., Wikkelsø, C., Blennow, K., Zetterberg, H., Constantinescu, R., Remes, A. M., Herukka, S., Hiltunen, M. O., Rauramaa, T. H., et al. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00309-z · Cited by 41
Self-citationDifferential proteomic profile of lumbar and ventricular cerebrospinal fluid
Rostgaard, N., Olsen, M. H., Ottenheijm, M. E., Drici, L., Simonsen, A. H., Plomgaard, P., Gredal, H., Poulsen, H. H., Zetterberg, H., Blennow, K., et al. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00405-0 · Cited by 39
Self-citationProgressive supranuclear palsy
Giagkou, N., Höglinger, G. U., & Stamelou, M. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.10.013 · Cited by 44
Lin, C.-W., Lai, T.-T., Chen, S., & Lin, C. (2022) · GeroScience · doi:10.1007/s11357-022-00576-6 · Cited by 40
Xiang, C., Cong, S., Tan, X., Ma, S., Liu, Y., Wang, H., & Cong, S. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00431-7 · Cited by 40
Liu, N., Liang, X., Chen, Y., & Xie, L. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102199 · Cited by 44
Biofluid biomarkers in Alzheimer’s disease and other neurodegenerative dementias
Zetterberg, H., & Bendlin, B. B. (2026) · Nature · doi:10.1038/s41586-025-10018-w · Cited by 45
Self-citationUCHL1 from serum and CSF is a candidate biomarker for amyotrophic lateral sclerosis
Li, R., Wang, J., Xie, W., Liu, J., & Wang, C. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51141 · Cited by 39
Wang, Z., Wang, R., Li, Y., Li, M., Zhang, Y., Jiang, L., Fan, J., Wang, Q., & Yang, D. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.631738 · Cited by 39
Ibudilast (MN-166) in amyotrophic lateral sclerosis- an open label, safety and pharmacodynamic trial
Babu, S., Hightower, B. G., Chan, J. G. M., Zürcher, N. R., Kivisäkk, P., Tseng, C.-E. J., Sanders, D. L., Robichaud, A., Banno, H., Evora, A., et al. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102672 · Cited by 39
The Challenge of Disease-Modifying Therapies in Parkinson’s Disease: Role of CSF Biomarkers
Paoletti, F. P., Gaetani, L., & Parnetti, L. (2020) · Biomolecules · doi:10.3390/biom10020335 · Cited by 38
Schwarz, A. J. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01027-4 · Cited by 40
Parkin, G. M., Corey‐Bloom, J., Snell, C. M., Castleton, J., & Thomas, E. A. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.04.017 · Cited by 36
Tangen, G. G., Nilsson, M. H., Stomrud, E., Palmqvist, S., & Hansson, O. (2022) · Neurology · doi:10.1212/wnl.0000000000201106 · Cited by 39
Self-citationAndréasson, U., Gobom, J., Delatour, V., Auclair, G., Noam, Y., Lee, S., Wen, J. W. H., Jeromin, A., Arslan, B., Maceski, A. M., et al. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2022-1181 · Cited by 38
Self-citationAlzheimer disease seen through the lens of sex and gender
Castro‐Aldrete, L., Einsiedler, M., Martínková, J., Depypere, H. T., Ang, T. F. A., Mielke, M. M., Sindi, S., Eyre, H. A., Au, R., Dimech, A. S., et al. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01071-0 · Cited by 46
Mengel, D., Liu, W., Glynn, R. J., Selkoe, D. J., Strydom, A., Lai, F., Rosas, H. D., Torres, A., Patsiogiannis, V., Skotko, B. G., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00593-7 · Cited by 36
Nance, J. (2020) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000918 · Cited by 39
Hong, S., Dobričić, V., Ohlei, O., Bos, I., Vos, S. J. B., Prokopenko, D., Tijms, B. M., Andréasson, U., Blennow, K., Vandenberghe, R. R., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12330 · Cited by 33
Self-citationRevendová, K. Ž., Zeman, D., Bunganic, R., Karasova, K., Volný, O., Bar, M., & Kušnierová, P. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104177 · Cited by 39
Bolsewig, K., Hok-A-Hin, Y. S., Sepe, F. N., Boonkamp, L., Jacobs, D., Bellomo, G., Paoletti, F. P., Vanmechelen, E., Teunissen, C. E., Parnetti, L., et al. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-220318 · Cited by 36
Self-citationNeurofilaments contribution in clinic: state of the art
Delaby, C., Bousiges, O., Bouvier, D., Fillée, C., Fourier, A., Mondésert, E., Nezry, N., Omar, S., Quadrio, I., Rucheton, B., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1034684 · Cited by 38
Neurofilament Light Protein Predicts Disease Progression in Idiopathic REM Sleep Behavior Disorder
Zhang, X., Ma, L., Liang, D., Song, B., Chen, J., Huang, Y., Xu, L., Zhao, P., Wu, W., Zhang, N., et al. (2023) · Journal of Parkinson s Disease · doi:10.3233/jpd-223519 · Cited by 35
Shahim, P., Norato, G., Sinaii, N., Zetterberg, H., Blennow, K., Chan, L. E., & Grunseich, C. (2024) · Genes · doi:10.3390/genes15040496 · Cited by 39
Self-citationCousins, K. A. Q., Phillips, J. S., Irwin, D. J., Lee, E. B., Wolk, D. A., Shaw, L. M. J., Zetterberg, H., Blennow, K., Burke, S., Kinney, N. G., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12233 · Cited by 38
Self-citationEratne, D., Janelidze, S., Malpas, C. B., Loi, S. M., Walterfang, M., Merritt, A. H., Diouf, I., Blennow, K., Zetterberg, H., Cilia, B.-J., et al. (2021) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674211058684 · Cited by 33
Self-citationBergström, S., Öijerstedt, L., Remnestål, J., Olofsson, J., Ullgren, A., Seelaar, H., Swieten, J. C. V., Synofzik, M., Sánchez‐Valle, R., Moreno, F., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00499-4 · Cited by 36
Self-citationTemporal trajectory of biofluid markers in Parkinson’s disease
Baek, M. S., Lee, M. J., Kim, H., & Lyoo, C. H. (2021) · Scientific Reports · doi:10.1038/s41598-021-94345-8 · Cited by 35
Burgess, B., Cho, E., & Honigberg, L. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-18716-5 · Cited by 35
Novel fluid biomarkers for mild cognitive impairment: A systematic review and meta-analysis
Gaur, A., Rivet, L., Mah, E., Bawa, K. K., Gallagher, D., Herrmann, N., & Lanctôt, K. L. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102046 · Cited by 37
Hofmann, A., Häsler, L. M., Lambert, M., Kaeser, S. A., Gräber‐Sultan, S., Obermüller, U., Kuder-Buletta, E., la Fougère, C., Laske, C., Vöglein, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52937-8 · Cited by 45
Self-citationLarsson, D., Åkerfeldt, T., Carlson, K. E., & Burman, J. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458519863983 · Cited by 35
Self-citationPlasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy
van Ballegoij, W. J. C., van de Stadt, S. I. W., Huffnagel, I. C., Kemp, S., Willemse, E. A. J., Teunissen, C. E., & Engelen, M. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51188 · Cited by 35
Self-citationWieske, L., Smyth, D., Lunn, M. P., Eftimov, F., & Teunissen, C. E. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01136-0 · Cited by 35
Self-citationPlasma ATN(I) classification and precision pharmacology in Alzheimer's disease
Imbimbo, B. P., Watling, M., Imbimbo, C., & Nisticò, R. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13084 · Cited by 34
Pedersen, C. C., Ushakova, A., Alves, G. W., Tysnes, O., Blennow, K., Zetterberg, H., Maple‐Grødem, J., & Lange, J. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00768-1 · Cited by 34
Self-citationNeurochemical biomarkers in amyotrophic lateral sclerosis
Verde, F., Silani, V., & Otto, M. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000744 · Cited by 36
CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study
Nissen, M. S., Ryding, M., Nilsson, A. C., Madsen, J. S., Olsen, D. A., Halekoh, U., Lydolph, M. C., Illés, Z., & Blaabjerg, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.719432 · Cited by 34
Alzheimer’s disease: From basic science to precision medicine approach
Forloni, G. (2020) · BMJ Neurology Open · doi:10.1136/bmjno-2020-000079 · Cited by 33
Metadata
- Authors
- Bridel, C., van Wieringen, W. N., Zetterberg, H., Tijms, B. M., Teunissen, C. E., and the NFL Group, Alvarez-Cermeño, J. C., Andreasson, U., Axelsson, M., Bäckström, D. C., Bartos, A., Bjerke, M., Blennow, K., Boxer, A., Brundin, L., Burman, J., Christensen, T., Fialová, L., Forsgren, L., Frederiksen, J. L., Gisslén, M., Gray, E., Gunnarsson, M., Hall, S., Hansson, O., Herbert, M. K., Jakobsson, J., Jessen-Krut, J., Janelidze, S., Johannsson, G., Jonsson, M., Kappos, L., Khademi, M., Khalil, M., Kuhle, J., Landén, M., Leinonen, V., Logroscino, G., Lu, C.-H., Lycke, J., Magdalinou, N. K., Malaspina, A., Mattsson, N., Meeter, L. H., Mehta, S. R., Modvig, S., Olsson, T., Paterson, R. W., Pérez-Santiago, J., Piehl, F., Pijnenburg, Y. A. L., Pyykkö, O. T., Ragnarsson, O., Rojas, J. C., Romme Christensen, J., Sandberg, L., Scherling, C. S., Schott, J. M., Sellebjerg, F. T., Simone, I. L., Skillbäck, T., Stilund, M., Sundström, P., Svenningsson, A., Tortelli, R., Tortorella, C., Trentini, A., Troiano, M., Turner, M. R., van Swieten, J. C., Vågberg, M., Verbeek, M. M., Villar, L. M., Visser, P. J., Wallin, A., Weiss, A., Wikkelsø, C., & Wild, E. J.
- Affiliations
- Amsterdam Neuroscience (NL)
- Department of Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam, the Netherlands
- Sahlgrenska University Hospital (SE)
- Hospital Universitario Ramón y Cajal (ES)
- Multiple Sclerosis Unit, Ramon y Cajal University Hospital, Madrid, Spain
- Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
- University of Gothenburg (SE)
- Charles University (CZ)
- Third Faculty of Medicine, Department of Neurology, Charles University and General University Hospital, Prague, Czech Republic
- University of Antwerp (BE)
- University of California, San Francisco (US)
- Karolinska University Hospital (SE)
- Uppsala University (SE)
- Aarhus University (DK)
- Copenhagen University Hospital (DK)
- University of Oxford (GB)
- Lund University (SE)
- University of Basel (CH)
- Department of Medicine, University Hospital and University of Basel, Basel, Switzerland
- University of Eastern Finland (FI)
- China Medical University Hospital (TW)
- National Hospital for Neurology and Neurosurgery (GB)
- Queen Mary University of London (GB)
- Erasmus MC (NL)
- University of Puerto Rico, Medical Sciences Campus (PR)
- Puerto Rico OMICS Centre, University of Puerto Rico Comprehensive Cancer Centre, San Juan
- Department of Neurology, Faculty of Medicine and Health, Orebro University Hospital, Orebro, Sweden
- Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
- Belmont University (US)
- Azienda Ospedaliera San Camillo-Forlanini (IT)
- Danderyds sjukhus (SE)
- Pia Fondazione di Culto e Religione Azienda Ospedaliera "Card. G. Panico" (IT)
- University of Ferrara (IT)
- Alzheimer Centre and Department of Neurology, Erasmus Medical Centre, Rotterdam, the Netherlands
- Radboud University Nijmegen (NL)
- Maastricht University (NL)
- Evotec (Germany) (DE)
- Corresponding author
- Bridel, Claire
- ORCID
- Bridel, Claire
- Zetterberg, Henrik
- Tijms, Betty M.
- Teunissen, Charlotte E.
- Axelsson, Markus
- Bäckström, David C.
- Bjerke, Maria
- Blennow, Kaj
- Boxer, Adam
- Brundin, Lou
- Burman, Joachim
- Christensen, Tove
- Fialová, Lenká
- Forsgren, Lars
- Frederiksen, Jette L.
- Gisslén, Magnus
- Gray, Elizabeth
- Hall, Sara
- Hansson, Oskar
- Herbert, Megan K.
- Jakobsson, Joel
- Janelidze, Shorena
- Johannsson, Gudmundur
- Jonsson, Michael
- Kappos, Ludwig
- Khademi, Mohsen
- Khalil, Michael
- Landén, Mikael
- Leinonen, Ville
- Logroscino, Giancarlo
- Lu, Ching-Hua
- Lycke, Jan
- Malaspina, Andrea
- Mattsson, Niklas
- Meeter, Lieke H.
- Mehta, Sanjay R.
- Modvig, Signe
- Olsson, Tomas
- Paterson, Ross W.
- Piehl, Fredrik
- Pijnenburg, Yolande A. L.
- Rojas, Julio C.
- Schott, Jonathan M.
- Sellebjerg, Finn T.
- Simone, Isabella L.
- Skillbäck, Tobias
- Stilund, Morten
- Sundström, Peter
- Svenningsson, Anders
- Tortelli, Rosanna
- Tortorella, Carla
- Trentini, Alessandro
- Turner, Martin R.
- Vågberg, Mattias
- Verbeek, Marcel M.
- Villar, Luisa M.
- Visser, Pieter Jelle
- Wallin, Anders
- Weiss, Andreas
- Wikkelsø, Carsten
- Wild, Edward J.
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2019-09-01
- Volume
- 76
- Issue
- 9
- Pages
- 1035
- ISSN
- 2168-6149 (ISSN-L)
- PMC
- PMC6580449
- OpenAlex
- W2950228559
- Cited by
- 764
- References
- 107
- Citations by year
- 2026: 76 · 2025: 116 · 2024: 115 · 2023: 105 · 2022: 119 · 2021: 108 · 2020: 102 · 2019: 21
- FWCI
- 65.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA Neurology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion, other-oa)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Eli Lilly and Company
- AstraZeneca
- Bayer
- Sanofi
- Biogen
- CHDI Foundation
- Teva Pharmaceutical Industries
- Itä-Suomen Yliopisto
- Universität Basel
- European Committee for Treatment and Research in Multiple Sclerosis
- EU Joint Programme – Neurodegenerative Disease Research
- European Federation of Pharmaceutical Industries and Associations (115372)
- European Huntington's Disease Network
- National Institute for Health and Care Research (CL-2016-18-004)
- Motor Neurone Disease Association (TURNER/OCT18/989-797, MALASPINA/APR13/817-791, MR/ K01014X/1, TURNER/OCT15/972-797)
- European Commission (HORIZON2020, 733050202, 115372, 633666)
- Bayer HealthCare
- National Research Foundation
- ZonMw (733050202, 733050822, 733050824)
- Radboud Universiteit
- Vrije Universiteit Amsterdam
- Universiteit Maastricht
- Gentofte Hospital
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (733050822)
- Karolinska Institutet
- Kuopion Yliopistollinen Sairaala
- China Medical University Hospital
- Sahlgrenska Universitetssjukhuset
- Università degli Studi di Ferrara
- China Medical University
- Red Española de Esclerosis Múltiple
- Karl-Franzens-Universität Graz
- Novo Nordisk Fonden (NNF17OC0026978)
- Medizinische Universität Graz
- Stichting Dioraphte
- Alzheimer Nederland
- H. Lundbeck A/S
- Barts Health NHS Trust
- Janssen Prevention Center
- Allergan
- University of California, San Diego
- Avid Radiopharmaceuticals
- Medical Research Council (MR/K01014X/1, MR/M008592/1)
- Economic and Social Research Council (ES/K000365/1)
- Instituto de Salud Carlos III
- National Institute on Aging (K23AG059888, P01AG019724, T32AG023481)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- neurofilament light chain, cerebrospinal fluid biomarkers, neuroaxonal damage, age and sex effects, differential diagnosis, frontotemporal dementia, HIV-associated neurocognitive disorders, amyotrophic lateral sclerosis, Huntington's disease, Alzheimer's disease, Parkinson's disease, multiple sclerosis, dementia, neuroinflammation, diagnostic accuracy, neurodegeneration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
